Among other prominent causes of the antitumor activity of MMR at a low dose is that IT injection of the vaccine may elicit a polymorphic immune response against each virus (measles, mumps, and rubella viruses) as well as tumor antigens. The gene discussed is MRC1; the disease is neoplasm.